EPO and anemia (phenotype): Concerning therapeutic interventions, EPO is applied for the treatment of anemia, and colony-stimulating factors are in use for the therapy of neutropenia, while other hematopoietic growth factors still need to demonstrate in vivo clinical relevance before reaching the market [24].